NCT05372354 2025-09-05A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaBristol-Myers SquibbPhase 1/2 Recruiting260 enrolled